38416 Federal Register / Vol. 63, No. 136 /Thursday, July 16, 1998 / Notices

ACTION: Notice.

SUMMARY: The Health Resources and

Services Administration (HRSA) is

requesting nominations to fill three

vacancies on the Advisory Commission

on Childhood Vaccines (ACCV). The

ACCV was established by Title XXI of

the Public Health Service Act (the Act),

as enacted by Public Law (Pub. L.) 99–

660 and as subsequently amended, and

advises the Secretary of Health and

Human Services (the Secretary) on

issues related to implementation of the

National Vaccine Injury Compensation

Program (VICP).

FOR FURTHER INFORMATION CONTACT: Ms.

Melissa Palmer, Principal Staff Liaison,

Policy and Commission Branch,

Division of Vaccine Injury

Compensation, at (301) 443–3196.

DATES: Nominations are to be submitted

by August 17, 1998.

ADDRESSES: All nominations are to be

submitted to the Director, Division of

Vaccine Injury Compensation, Bureau of

Health Professions, HRSA, Parklawn

Building, Room 8A–35, 5600 Fishers

Lane, Rockville, Maryland 20857.

SUPPLEMENTARY INFORMATION: Under the

authorities that established the ACCV,

viz., the Federal Advisory Committee

Act of October 6, 1972 (P.L. 92–463) and

section 2119 of the Act, 42 U.S.C.

300aa–19, as added by P.L. 99–660 and

amended, HRSA is requesting

nominations for three voting members

of the ACCV.

The ACCV advises the Secretary on

the implementation of the VICP; on its

own initiative or as the result of the

filing of a petition, recommends changes

in the Vaccine Injury Table; advises the

Secretary in implementing the

Secretary’s responsibilities under

section 2127 regarding the need for

childhood vaccination products that

result in fewer or no significant adverse

reactions; surveys Federal, State, and

local programs and activities relating to

the gathering of information on injuries

associated with the administration of

childhood vaccines, including the

adverse reaction reporting requirements

of section 2125(b); advises the Secretary

on means to obtain, compile, publish,

and use credible data related to the

frequency and severity of adverse

reactions associated with childhood

vaccines; and recommends to the

Director, National Vaccine Program

Office, research related to vaccine

injuries which should be conducted to

carry out the VICP.

The ACCV consists of nine voting

members appointed by the Secretary as

follows: three health professionals, of

whom at least two are pediatricians,

who are not employees of the United

States, who have expertise in the health

care of children, the epidemiology,

etiology and prevention of childhood

diseases, and the adverse reactions

associated with vaccines; three members

from the general public, of whom at

least two are legal representatives

(parents or guardians) of children who

have suffered a vaccine-related injury or

death; and three attorneys, of whom at

least one shall be an attorney whose

specialty includes representation of

persons who have suffered a vaccinerelated injury or death, and one shall be

an attorney whose specialty includes

representation of vaccine

manufacturers. In addition, the Director

of the National Institutes of Health, the

Assistant Secretary for Health and

Surgeon General, the Director of the

Centers for Disease Control and

Prevention, and the Commissioner of

the Food and Drug Administration (or

the designees of such officials) serve as

nonvoting ex officio members.

Specifically, HRSA is requesting

nominations for three voting members

of the ACCV representing: (1) a health

professional with special experience in

childhood diseases; (2) an attorney

whose specialty includes representation

of persons who have suffered a vaccinerelated injury or death; and (3) a

member from the general public who is

a legal representative (parent or

guardian) of a child (or children) who

has suffered a vaccine-related injury or

death. Nominees will be invited to serve

3-year terms beginning January 1, 1999,

and ending December 31, 2001.

Interested persons may nominate one

or more qualified persons for

membership on the ACCV. Nominations

shall state that the nominee is willing to

serve as a member of the ACCV and

appears to have no conflict of interest

that would preclude the ACCV

membership. Potential candidates will

be asked to provide detailed information

concerning such matters as financial

holdings, consultancies, and research

grants or contracts to permit evaluation

of possible sources of conflicts of

interest. A curriculum vitae or re ́sume ́

should be submitted with the

nomination.

The Department of Health and Human

Services has special interest in assuring

that women, minority groups, and the

physically handicapped are adequately

represented on advisory committees and

therefore extends particular

encouragement to nominations for

appropriately qualified female,

minority, or physically handicapped

candidates.

Dated: July 10, 1998.

Claude Earl Fox,

Administrator.

[FR Doc. 98–18954 Filed 7–15–98; 8:45 am]

BILLING CODE 4160–15–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Project Grants for Health Care and

Other Facilities

AGENCY: Health Resources and Services

Administration, HHS.

ACTION: Notice of limited competition

for grant funds.

SUMMARY: The Health Resources and

Services Administration (HRSA)

announces a limited competition to

provide $510,203 in construction

funding to Iowa hospitals which were

recipients of Rural Health Transition

Grants from the Health Care Financing

Administration. Funds were

appropriated for this purpose by Public

Law 105–78 under the Public Health

Service Act.

Funds are available to support one or

two construction/renovation projects. In

accordance with the directive set forth

in the House and Senate Conference

Report on Public Law 105–78,

competition is limited to the hospitals

listed below (H.R. Report No. 105–390,

dated November 7, 1997). Award

consideration will be limited to the

following Iowa facilities:

Adair County Memorial Hospital, Greenfield;

Audubon County Memorial Hospital,

Audubon;

Cass County Memorial Hospital, Atlantic;

Davis County Hospital, Bloomfield;

Greene County Medical Center, Jefferson;

Guthrie County Hospital, Guthrie Center;

Hamilton County Public Hospital, Webster

City;

Horn Memorial Hospital, Ida Grove;

Mahaska County Hospital, Oskaloosa;

Manning General Hospital, Manning;

Monroe County Hospital, Albia;

Montgomery County Memorial Hospital, Red

Oak;

Palo Alto County Hospital, Emmetsburg;

Ringgold County Hospital, Mount Ayr;

St. Anthony Regional Hospital, Carroll;

St Joseph’s Mercy Hospital, Centerville;

Story County Hospital, Nevada;

Van Buren County Hospital, Xerosauqua;

Washington County Hospital, Washington;

Wayne County Hospital, Corydon;

Winneshiek County Memorial Hospital,

Decorah.

Other Award Information: HHS

strongly encourages all grant and

contract recipients to provide a smoke

free workplace and to promote the
Federal Register / Vol. 63, No. 136 /Thursday, July 16, 1998 / Notices 38417

nonuse of all tobacco products. In

addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking

in certain facilities (or in some cases,

any portion of a facility) in which

regular or routine education, library,

day care, health care, or early childhood

development services are provided to

children.

FOR FURTHER INFORMATION CONTACT:

Additional information relating to

technical and program issues may be

obtained from Mr. Paul Murphy, Chief,

Facilities Monitoring Branch, Division

of Facilities Compliance and Recovery,

Office of Special Programs, HRSA,

Twinbrook Metro Plaza Building, 12300

Twinbrook Parkway, Suite 520,

Rockville, Maryland 20857, (301) 443–

4303. Information regarding business,

administrative, or fiscal issues related to

the awarding of grants under this Notice

may be requested from Mr. Tom

Castonguay, Grants Management

Specialist, HIV/AIDS Bureau, HRSA,

Parklawn Building, Room 7–27, 5600

Fishers Lane, Rockville, Maryland

20857, 301 443–2385. Applicants for

grants will use Form PHS 5161–1,

approved under OMB Control Number

0937–0189.

The OMB Catalog of Federal Domestic

Assistance number for Health Care Facilities

is 93.887.

Dated: July 10, 1998.

Claude Earl Fox,

Administrator.

[FR Doc. 98–18953 Filed 7–15–98; 8:45 am]

BILLING CODE 4160–15–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5,

U.S.C., as amended. The grant

applications and the discussions could

disclose confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with

the grant applications, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Phase I

Trial: Autologous, Tumor-pulsed Dendritic

Cells.

Date: August 3–4, 1998.

Time: 8:00 AM to 6:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, MD 20910.

Contact Person: Martin H. Goldrosen, PhD,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, National

Institutes of Health, 6130 Executive

Boulevard, Room 635C, Rockville, MD

20852–7408, (301) 496–7930.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: July 10, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–18926 Filed 7–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Environmental

Health Sciences; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Environmental Health Sciences Special

Emphasis Panel, RFA 98–003—Peroxisome

Proliferators and Mechanisms of

Carcinogenesis.

Date: July 22, 1998.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIEHS-East Campus, 79 T.W.

Alexander Drive, Bldg. 4401, Room 3162,

Research Triangle Park, NC 27709.

Contact Person: Carol K. Shreffler, Ph.D.,

Health Scientist Administrator, 104 T.W.

Alexander Drive, Research Triangle Park, NC

27709, (919) 541–1445.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute of

Environmental Health Sciences Special

Emphasis Panel, Probing for Substrate

Binding Residues of Mammalian FMOs.

Date: July 28, 1998.

Time: 1:00 PM to 3:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIEHS, 79 T.W. Alexander Drive,

Building 4401, Conference Room 3446,

Research Triangle Park, NC 27709,

(Telephone Conference Call).

Contact Person: David Brown, MPH, Nat’l

Institute of Environmental Health Sciences,

P.O. Box 12233, Research Triangle Park, NC

27709, (919) 541–4964.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute of

Environmental Health Sciences Special

Emphasis Panel, Lead and CaMPKII

Modulation of Hair Cells.

Date: July 29, 1998.

Time: 1:00 PM to 3:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIEHS, 79 T.W. Alexander Drive,

Building 4401, Conference Room 3446,

Research Triangle Park, NC 27709,

(Telephone Conference Call).

Contact Person: David Brown, MPH, Nat’l

Institute of Environmental Health Sciences,

P.O. Box 12233, Research Triangle Park, NC

27709, (919) 541–4964.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.115, Biometry and Risk

Estimation—Health Risks from

Environmental Exposures; 93.142, NIEHS

Hazardous Waste Worker Health and Safety

Training; 93.143, NIEHS Superfund

Hazardous Substances—Basic Research and

Education; 93.894, Resources and Manpower

Development in the Environmental Health

Sciences; 93.113, Biological Response to

Environmental Health Hazards; 93.114,

Applied Toxicological Research and Testing,

National Institutes of Health, HHS)

Dated: July 10, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–18924 Filed 7–15–98; 8:45 am]

BILLING CODE 4140–01–M